Search Results
1,647 results
Your search is now limited to «HIV/AIDS» expert search.
WN.com 04/20/2019 13:21
The Centers for Disease Control and Prevention (CDC) released a “Dear Colleague” letter Wednesday with warnings about the high prevalence and risk of human immunodeficiency virus (HIV) among transgender individuals.
More from WN.com:
FeedNavigator (EU) 04/20/2019 10:38
Background Diabetes prevalence in HIV is not well characterized for India, despite the high burden of both individual diseases.
More from FeedNavigator (EU):
Public Health - Seattle & King County says the spike in diagnoses of HIV has affected heterosexual homeless men using drugs intravenously and women who are sex workers.
More from Washington Times (United States):
PR Newswire 04/19/2019 13:17
Gilead Sciences' safer anti-viral HIV treatment formulation, tenofovir alafenamide fumarate (TAF), was patented in 2015, extending the company's dominance in HIV/AIDS drugs until 2038.
More from PR Newswire:
ClinicalTrials.gov 04/19/2019 08:10
Although antiretroviral therapy (ART) efficiently suppresses viral replication HIV persists in CD4+ T cells in a form that is neither targeted by the immune system nor by ART, the complete eradication of replication competent HIV or the establishment of a long term remission state in infected individuals represents an outstanding challenge ...
More from ClinicalTrials.gov:
MedPageToday.com 04/18/2019 16:30
Wang and colleagues also described the use of broadly neutralizing HIV-specific monoclonal antibodies (bNAbs) instead of ART as a "formidable clinical challenge" in the treatment of HIV, due to the emergence of antibody-resistant virus.
More from MedPageToday.com:
DoctorsLounge 04/18/2019 13:00
Suppression maintained for up to 16 weeks in HIV-infected undergoing analytic treatment interruption.
More from DoctorsLounge:
Lifeboat News: The Blog 04/18/2019 12:24
Previous experimental infusions of broadly neutralizing antibodies, or bNAbs, have suppressed HIV for about two weeks by targeting proteins on the virus itself, but the rapid mutation rate of HIV induces antibody-resistant strains that render the treatment ineffective.
More from Lifeboat News: The Blog:
News-Medical.net 04/18/2019 12:06
Patients infected with HIV are currently treated with a cocktail of antiretroviral drugs designed to prevent the replication of the virus within the body and delay the onset of AIDS.
More from News-Medical.net:
New HIV therapy may suppress virus for months.
More from United Press International - UPI (United States):
Previous experimental infusions of broadly neutralising antibodies, or bNAbs, have suppressed HIV for around two weeks by targeting proteins on the virus itself, but the rapid mutation rate of HIV induces antibody-resistant strains that render the treatment ineffective.
More from European Pharmaceutical Review:
Business Wire 04/18/2019 10:45
Since, 2009 AIDS Healthcare Foundation (AHF), the world’s largest, non-profit, HIV/AIDS service organization, has been in the District of Columbia, serving as a leading non-profit agency in the fight against AIDS.
More from Business Wire:
Public Health Newswire 04/18/2019 09:48
TIME – How an experimental injection could revolutionize HIV treatment HIV treatment has come a long way since the early days of the epidemic.
More from Public Health Newswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications